InfuSystem Holdings, Inc. (AMEX: INFU) is a Healthcare company (Medical - Devices) with a market capitalization of $296M. The Maz Rating grades it against the other companies in its sector.
InfuSystem Holdings, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $14.79, InfuSystem Holdings, Inc. trades at 31.6x trailing earnings, 2.1x sales and 4.6x book value, with an EV/EBITDA of 11.8. Over the last twelve months it generated about $144M of revenue and $9M of net income. It runs a gross margin of 57.6%, an operating margin of 9.8% and a net margin of 6.5%. It shows return on equity of 15.8%, return on invested capital of 11.6% and a free cash flow yield of 4.5%. On the balance sheet: a debt-to-equity ratio of 0.35 and a current ratio of 2.68. Over the past 52 weeks the share price ranged from $7.29 to $15.47, with a beta of 1.38.
InfuSystem Holdings, Inc. does not currently pay a dividend.
4 Wall Street analyst ratings cover the stock: 4 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.